Loading…
Lobbying Spend
—
Filings
103
Firms Hired
3
Active Period
1999–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
American Taxpayer Relief Act of 2012
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R.1285
Safeguarding America's Pharmaceuticals Act of 2013
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1919
School Access to Emergency Epinephrine Act
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2094
Patients' Access to Treatments Act of 2013
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R.460
Stop Tampering of Prescription Pills Act of 2013
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 486
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Client expense: — · Firm income: $60,000
Matched citations: H.R.5013
Patent Abuse Reduction Act of 2013
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: S.1013
Patent Transparency and Improvements Act of 2013
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: S.1720
Preserve Access to Affordable Generics Act
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: S.214
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Client expense: — · Firm income: $60,000
Matched citations: S.2389
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Client expense: — · Firm income: $60,000
Matched citations: S.2499
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: S.504
Safe Prescribing Act of 2013
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: S.621
Drug Supply Chain Security Act
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: S. 957
Pharmaceutical Quality, Security, and Accountability Act
2014 · fourth_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: S. 959
American Taxpayer Relief Act of 2012
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 8
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R.1285
Safeguarding America's Pharmaceuticals Act of 2013
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1919
School Access to Emergency Epinephrine Act
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 2094
Patients' Access to Treatments Act of 2013
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R.460
Stop Tampering of Prescription Pills Act of 2013
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Client expense: — · Firm income: $60,000
Matched citations: H.R. 486
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Client expense: — · Firm income: $60,000
Matched citations: H.R.5013
Patent Abuse Reduction Act of 2013
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: S.1013
Patent Transparency and Improvements Act of 2013
2014 · third_quarter · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Client expense: — · Firm income: $60,000
Matched citations: S.1720
Source: Senate LDA